Rankings
▼
Calendar
▼
CYCN Q3 2017 Earnings Report — Cyclerion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Cyclerion Therapeutics, Inc.
CYCN
Q3 2017 Earnings
Reported September 29, 2017
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q3 2017
Q2 2017
Q3 2016
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$25M
—
—
—
—
EPS (Diluted)
$-18.38
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$315.0K
GROSS PROFIT
-$315.0K
R&D Expenses
$21M
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$4M
Other Expenses
$0
Operating Expenses
$25M
Cost & Expenses
$25M
OPERATING INCOME
-$25M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$0
INCOME BEFORE TAX
-$25M
Income Tax Expense
$0
Net Income from Continuing Ops
-$25M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$25M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$25M
D&A
$315.0K
EBIT
-$25M
EBITDA
-$25M
EPS
-$18
EPS Diluted
-$18
marketcaparena.com
← FY 2017
CYCN Overview
Q4 2017 →